Good pasture’s syndrome is characterised by ?
The core concept here is the pathophysiology of Goodpasture's. The key is the anti-GBM antibodies targeting the basement membrane. I should mention the type IV collagen alpha-3 chain as the antigen. That's a high-yield point for exams.
For the correct answer, since the options are missing, I'll have to assume the correct one is about anti-GBM antibodies. The explanation should detail how these antibodies cause damage in the kidneys and lungs. Maybe mention the HLA-DR2 and DR3 association as well.
Now, the wrong options. Common distractors might include other autoimmune conditions like lupus or vasculitis. Each needs a brief dismissal. For example, if an option says it's a type II hypersensitivity, that's wrong because it's type II, but maybe the user mixed up types. Wait, Goodpasture's is type II, so if an option says type III, that's incorrect. Also, other diseases with similar presentations like ANCA vasculitis should be mentioned as incorrect.
Clinical pearl: Remember the classic triad, but note that not all patients have all three. Also, the importance of early treatment with plasmapheresis and immunosuppressants.
Need to check that all sections are covered: Core Concept, Why Correct, Why Incorrects, Clinical Pearl, and Correct Answer. Keep each section concise, within the character limit. Use bold for key terms. Avoid markdown headers, just bold labels. Make sure the answer is labeled correctly. Let me structure each part step by step, ensuring clarity and adherence to the user's formatting rules.
**Core Concept**
Goodpasture’s syndrome is an autoimmune disease characterized by **anti-glomerular basement membrane (anti-GBM) antibodies** targeting the alpha-3 chain of type IV collagen. It causes rapidly progressive glomerulonephritis and pulmonary hemorrhage, linked to HLA-DR2/DR3 alleles.
**Why the Correct Answer is Right**
The disease involves **type II hypersensitivity** where autoantibodies bind to basement membranes in kidneys and lungs, triggering complement activation and neutrophil-mediated tissue damage. Anti-GBM antibodies are diagnostic, detected via indirect immunofluorescence showing linear deposits in renal glomeruli. Early treatment with **plasmapheresis** and immunosuppressants (e.g., cyclophosphamide) is critical to prevent renal failure.
**Why Each Wrong Option is Incorrect**
**Option A:** *If it states “anti-nuclear antibodies (ANA)”* — ANA are hallmark of systemic lupus erythematosus, not Goodpasture’s.
**Option B:** *If it lists “c-ANCA or p-ANCA”* — These are markers of ANCA-associated vasculitis (e.g., GPA), which present with granulomatous inflammation, not anti-GBM antibodies.
**Option C:** *